Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2016

Jun 9, 2016

33431_dirs_2016-06-09_e260adc5-dfbb-4f74-8182-d8d4aa649add.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-06-07

Reporting Person: Midyett Ronald Lane (Chief Operations Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-07 Common Stock M 10000 $11.54 Acquired 115188 Direct
2016-06-07 Common Stock M 3719 Disposed 111469 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-06-07 Restricted Stock Unit (RSU) $ M 10000 Disposed 2016-06-07 Common Stock (10000) Direct

Footnotes

F1: Restricted Stock Units vested on June 7, 2016.

F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis

F3: Mr Midyett surrendered to the Issuer the right to receive an aggregate of 3,719 shares of Common Stock. Mr. Midyett did not sell any shares of Common Stock in connection with the foregoing exercise.